紅太陽(000525.SZ):紅太陽集團減持期屆滿1股未減 或繼續被動減持公司股份
格隆匯3月22日丨紅太陽(000525.SZ)公佈,截至2021年3月19日,紅太陽集團持有公司股份4645.9663萬股,佔公司總股本的8.00%,為公司持股5%以上股東。截至目前,紅太陽集團此次減持計劃期滿,其在減持計劃期間未減持公司股份。
另外,紅太陽集團因質押、融資、債務等違約而被質權人、債權人或相關主體等可能實施減持,採取集中競價方式減持的,在任意連續90個自然日內,擬減持股份的總數不超過公司股份總數的1%;採取大宗交易方式減持的,在任意連續90個自然日內,擬減持股份的總數不超過公司股份總數的2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.